Discover 878 paid clinical trials in Kentucky. Search by city or condition to find a research study near you that matches your needs across various therapeutic areas.
Kentucky presents diverse clinical research opportunities for healthy volunteers looking to get involved in paid studies, and those with specific health conditions alike. Major research centers in Louisville, Lexington, and Bowling Green are actively seeking participants, offering access to new treatments and advanced medical care.
Filter
1
Filter results
Results: 878
Betadine vs Sterile Water for Periurethral Preparation
for
Catherization, Urinary Tract Infection Bacterial
Location: Louisville KY
Sponsor: University of Louisville
Sex: Female
Age: 18+
Code: NCT07044726
Recruiting
A Study to Evaluate the Efficacy, Safety, and Drug Levels of Deucravacitinib (BMS-986165) in Adolescent Participants With Moderate to Severe Plaque Psoriasis
for
Plaque Psoriasis
Location: St. John's, Milford MA, Philadelphia PA, Rockville MD,
Sponsor: Bristol-Myers Squibb
Sex: All
Age: 12 - 17
Code: NCT06979453
Phase 3, Recruiting
Study to Evaluate the Efficacy and Safety of Deuruxolitinib in Adolescents With Severe Alopecia Areata
A Study of Investigational Agents in Participants With Previously Treated Stage IV Nonsquamous Non-small Cell Lung Cancer (NSCLC) (MK-3475-01H/KEYMAKER-U01)
for
Carcinoma, Non-Small-Cell Lung
Location: Baltimore MD, Pittsburgh PA, Lexington KY
Sponsor: Merck Sharp & Dohme LLC
Sex: All
Age: 18+
Code: NCT06780085
Phase 2, Recruiting
Hypofractionated Radiochemotherapy
for
Uterine Cervix Cancer
Location: Lexington KY
Sponsor: Denise Fabian
Sex: Female
Age: 18 - 70+
Code: NCT06331468
Phase 2, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Testing Conversational Agents as a Digital Companion
for
Autism
Location: Muncie IN, Louisville KY, Bloomington IN
Sponsor: Friendi.fi Corporation
Sex: All
Age: 18 - 35
Code: NCT07533331
Recruiting
Phase 3 Study of Gedatolisib as First-Line Treatment for Patients With HR-Positive, HER2-Negative Advanced Breast Cancer (VIKTORIA-2)
for
Breast Cancer
Location: Westbury NY, New York NY, Midlothian VA, Plantation FL,
Sponsor: Celcuity Inc
Sex: All
Age: 18+
Code: NCT06757634
Phase 3, Recruiting
Imeroprubart in Adult Participants With Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)
for
Chronic Inflammatory Demyelinating Polyneuropathy
Location: Boston MA, Worcester MA, New Haven CT, New York NY,
Sponsor: Immunovant Sciences GmbH
Sex: All
Age: 18+
Code: NCT07032662
Phase 2, Recruiting
A Phase 3 Efficacy and Safety Study of Fosmanogepix for the Treatment of Adult Patients With Invasive Mold Infections.
for
Invasive Mold Infections
Location: New York NY, Philadelphia PA, Baltimore MD, Ottawa,
Sponsor: Basilea Pharmaceutica
Sex: All
Age: 18+
Code: NCT06925321
Phase 3, Recruiting
Effect of Inhaled Technosphere Insulin vs RAA Insulin on Exercise-Induced Hypoglycemia in Adults With T1D Using Automated Insulin Delivery
for
Diabetes Mellitus, Type 1
Location: Philadelphia PA, Louisville KY, Seattle WA
Sponsor: Jaeb Center for Health Research
Sex: All
Age: 18 - 65
Code: NCT06880835
Recruiting
A Phase III Study of AZD0780 on Major Adverse CV Events in Patients With a History of ASCVD Events or at High Risk for a First Event
Docetaxel to Androgen Receptor Pathway Inhibitors in Patients With Metastatic Castration Sensitive Prostate Cancer and Suboptimal PSA Response
for
Prostate Cancer (Adenocarcinoma)
Location: Saint John, Providence RI, Saint Johnsbury VT,
Sponsor: Canadian Cancer Trials Group
Sex: Male
Age: 18+
Code: NCT06592924
Phase 3, Recruiting
Fluid Management of Acute Decompensated Heart Failure Subjects Treated With Reprieve System (FASTR-II) (IDE-G210258)
for
Acute Decompensated Heart Failure
Location: Philadelphia PA, Richmond VA, Falls Church VA,
Sponsor: Reprieve Cardiovascular, Inc
Sex: All
Age: 22+
Code: NCT06898515
Recruiting
Substudy 01I: A Study of Investigational Agents in Participants With Previously Treated Stage IV Squamous Non-small Cell Lung Cancer (NSCLC) (MK-3475-01I/KEYMAKER-U01I)
for
Lung Neoplasm
Location: Baltimore MD, Fairfax VA, Lexington KY, Dallas TX
Sponsor: Merck Sharp & Dohme LLC
Sex: All
Age: 18+
Code: NCT06780098
Phase 2, Recruiting
Study to Evaluate the Efficacy and Safety of [177Lu]Lu-DOTA-TATE in Patients With Grade 1 and Grade 2 Advanced GEP-NET
for
Somatostatin Receptor Positive (SSTR+),
Location: Hartford CT, New Haven CT, New York NY, Montreal,
Sponsor: Novartis Pharmaceuticals
Sex: All
Age: 12 - 70+
Code: NCT06784752
Phase 3, Recruiting
A Study to Investigate the Safety and Preliminary Efficacy of ALLO-329, an Allogeneic CAR T-cell Therapy, in Adults With Autoimmune Disease
for
Systemic Lupus Erythematosus (With and Without Nephritis),
Location: New York NY, East Brunswick NJ, Montreal, Baltimore MD,
Sponsor: Allogene Therapeutics
Sex: All
Age: 18 - 70+
Code: NCT07085104
Phase 1, Recruiting
Ataciguat for Slowing the Progression of Moderate Calcific Aortic Valve Stenosis: A Randomized, Placebo Controlled Study
for
Moderate Aortic Valve Stenosis
Location: Boston MA, Quebec, The Bronx NY, Albany NY, Montreal,